Titel

Merkliste
1 Ergebnisse

Dupilumab Provides Favorable Safety and Sustained Efficacy ..:

Beck, Lisa A ; Thaçi, Diamant ; Deleuran, Mette...
Beck , L A , Thaçi , D , Deleuran , M , Blauvelt , A , Bissonnette , R , de Bruin-Weller , M , Hide , M , Sher , L , Hussain , I , Chen , Z , Khokhar , F A , Beazley , B , Ruddy , M , Patel , N , Graham , N M H , Ardeleanu , M & Shumel , B 2020 , ' Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis ' , American Journal of Clinical Dermatology , vol. 21 , no. 4 , pp. 567-577 . https://doi.org/10.1007/s40257-020-00527-x. , 2020

Link: https://pure.au.dk/portal/da/publications/dupilumab-pr..

RT Journal
T1 <Title>Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftuniaarhuspubl:oai:pure.atira.dk:publications_d43cd3a3-b1d6-4de7-93c0-1dea192c96af&Exemplar=1&LAN=DE
				
A1 Beck, Lisa A
A1 Thaçi, Diamant
A1 Deleuran, Mette
A1 Blauvelt, Andrew
A1 Bissonnette, Robert
A1 de Bruin-Weller, Marjolein
A1 Hide, Michihiro
A1 Sher, Lawrence
A1 Hussain, Iftikhar
A1 Chen, Zhen
A1 Khokhar, Faisal A
A1 Beazley, Bethany
A1 Ruddy, Marcella
A1 Patel, Naimish
A1 Graham, Neil M.H
A1 Ardeleanu, Marius
A1 Shumel, Brad
YR 2020
JF Beck , L A , Thaçi , D , Deleuran , M , Blauvelt , A , Bissonnette , R , de Bruin-Weller , M , Hide , M , Sher , L , Hussain , I , Chen , Z , Khokhar , F A , Beazley , B , Ruddy , M , Patel , N , Graham , N M H , Ardeleanu , M & Shumel , B 2020 , ' Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis ' , American Journal of Clinical Dermatology , vol. 21 , no. 4 , pp. 567-577 . https://doi.org/10.1007/s40257-020-00527-x
LK http://dx.doi.org/https://pure.au.dk/portal/da/publications/dupilumab-provides-favorable-safety-and-sustained-efficacy-for-up-to-3-years-in-an-openlabel-study-of-adults-with-moderatetosevere-atopic-dermatitis(d43cd3a3-b1d6-4de7-93c0-1dea192c96af).html
DO https://pure.au.dk/portal/da/publications/dupilumab-provides-favorable-safety-and-sustained-efficacy-for-up-to-3-years-in-an-openlabel-study-of-adults-with-moderatetosevere-atopic-dermatitis(d43cd3a3-b1d6-4de7-93c0-1dea192c96af).html
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)